NALHN - Proposed Restructure – Oncology Clinical Trials Unit - Member Feedback Sought

14 August 2018

NALHN has invited the Public Service Association (PSA) to provide feedback about the above proposed restructure. The restructure is proposed to be trialled for 12 months with a review prior to completion to ascertain if the proposed structure meets the needs of the Clinical Trials Unit.

Salaried staff are in-scope in these proposals which include creation of three new roles and non-retention of the current temporary (ASO5) Clinical Trials Manager position that expires in January 2019.

The PSA is seeking feedback by email from members to include in the PSA's response to the employer. A copy of the consultation papers can be found below:


Please forward any comments to PSA  by email by close of business Wednesday 22 August 2018 to allow them to be included in a collated and non-identifying manner in the PSA's response.